Patients at risk for heart disease experienced significant reductions in apolipoprotein B and LDL cholesterol levels on ...

Eli Lilly (NYSE: LLY) is advancing its ambitions in cardiometabolic medicine with new mid-stage data showing that solbinsiran ...

Apolipoprotein B concentration is the strongest lipid-associated predictor of cardiovascular events. However, in patients who require lipid-lowering therapy, LDL cholesterol is the primary ...

HDL-cholesterol (HDL-C), HDL2-cholesterol (HDL2-C), HDL3-cholesterol (HDL3-C), apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), and lipoprotein (a) (Lp(a)) were determined. Results: In study 1 ...

Finally, all statistical models included apo B to account for differences in the proatherogenic lipoprotein fraction. In the IDEAL study, we observed that plasma levels of HDL-C were indeed ...